Northwestern Medical Group

Chicago, Illinois 60642

4 studies enrolling now · 27 studies all time

What they study most

Adenoid Cystic Carcinoma, Adult Growth Hormone Deficiency, Age - Related Macular Degeneration (AMD), Alopecia Areata, Brain Neoplasms, Brain Neoplasms, Primary, Cancer of the Prostate, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell of Head and Neck, Cardiac Disease, Cervical Cancer, Cholangiocarcinoma

Studies at this site

• Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease — Recruiting now
• Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD — Recruiting now
• Clarifying the Optimal Application of SLT Therapy Trial — Recruiting now
• Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors — Running, not enrolling
• Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) — Running, not enrolling
• Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors — Completed
• A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors — Stopped early
• A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information — Enrolling by invitation
• MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb — Running, not enrolling
• Long-Term PF-06651600 for the Treatment of Alopecia Areata — Completed
• Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer — Completed
• A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors — Stopped early
• A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement — Stopped early
• Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy — Completed
• Retropubic vs. Single-Incision Mid-Urethral Sling for Stress Urinary Incontinence — Completed
• A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B — Completed
• Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD) — Completed
• Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension — Completed
• The Smart Hypertension Control Study — Completed
• PF-06651600 for the Treatment of Alopecia Areata — Completed
• Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis — Stopped early
• A Phase 2 RCT Study of CX-8998 for Essential Tremor — Completed
• A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated. — Completed
• DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY — Completed
• Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy — NO_LONGER_AVAILABLE
• Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy — Completed
• Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma — Status unconfirmed